menu
ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

AVAX TECHNOLOGIES (AVXT)
0.0022 -0.002 (-45%)  11-17 13:58
Open: 0.0022 Prev Close: 0.004
High: 0.0022 Low: 0.0022
Volume: 30,035 Market Cap: 1.52M
Year High: 0.0096 Year Low: 0.001
Stock Technical Analysis
Overall       
Targets Six months: 0.0038    One year: 0.0053
Supports Support1: 0.0012   Support2: 0.0010
Resistances Resistance1: 0.0032    Resistance2: 0.0045 
Pivot Point 0.0017 
Moving Averages MA(5): 0.0020      MA(20): 0.0018 

MA(100): 0.0024  -1     MA(250): 0.0030 
MACD MACD(12,26):       Signal(12,26,9):  
Stochastic Oscillator %K(14,3): 45.238      %D(3): 26.190 
RSI RSI(14): 51.406 
52-Week High: 0.0096  Low: 0.0010  Change(%): -51
Average Volume(K) 3-Month: 6771  10-Days: 3901
Moving Averages analysis
Price and moving averages has closed above its Short term moving average. Short term moving average is below its mid-term; and below long term moving averages. From the relationship between price and moving averages; we can see that: this stock is NEUTRAL in short-term; and BEARISH in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed below upper band by 34%; above bottom band by 66%; Bollinger Bands are 3.3% wider than normal.The current width of the bands does not suggest anything about the future direction or movement of prices.

Stoxline

Stock Chart

Top 100 stocks

Stock News
AVAX Technologies, Inc. Announces the Appointment of Chief Executive Officer
Mon, 19 Oct 2015 12:04:03 GMT

AVAX Technologies Announces Results Of Its OVAX, Ovarian Cancer Vaccine, Phase ...
Tue, 26 Jan 2016 23:11:16 GMT

AVAX TECHS INCORPORATED (OTCMKTS:AVXT) Just Reported Decreased Shorts
Fri, 17 Nov 2017 11:03:45 GMT

Heat Biologics Appoints Dr. John Prendergast to Board of Directors
Mon, 25 Apr 2016 10:52:30 GMT

Global Personalized Cancer Vaccines & Clinical Innovation Outlook 2017-2022 ...
Thu, 23 Feb 2017 14:36:49 GMT

Philadelphia biotech firm resolves debt dispute with cancer hospital
Wed, 05 Aug 2015 17:48:45 GMT

Ironwood Investment Management Has Upped Its Aurinia Pharmaceuticals (AUPH ...
Sun, 12 Nov 2017 13:14:01 GMT

Stephens Investment Management Group Has Cut Its Svb Finl Group (SIVB) Stake ...
Fri, 03 Nov 2017 19:30:00 GMT

​Five things you don't know about Jeff Jonas, CEO of Sage Therapeutics
Fri, 12 Jun 2015 18:55:49 GMT

Cancer Immunotherapy, Part 2: Efficacy, Safety, and Other Clinical Considerations
Fri, 23 Jun 2017 15:02:33 GMT